Back to Search
GEORGE GROTH, M.D.
M.D.
Internal Medicine Physician
NPI: 1487759825Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
G38045(CA)
Research & Publications (20)
Structure of the c14 rotor ring of the proton translocating chloroplast ATP synthase.
PMID 19423706·J Biol Chem·2009
8-other
Ethylene signaling: identification of a putative ETR1-AHP1 phosphorelay complex by fluorescence spectroscopy.
PMID 18384742·Anal Biochem·2008
8-other
Molecular processes of inhibition and stimulation of ATP synthase caused by the phytotoxin tentoxin.
PMID 18579520·J Biol Chem·2008
8-other
Effects of pleiotrophin, a heparin-binding growth factor, on human primary and immortalized chondrocytes.
PMID 16949312·Osteoarthritis Cartilage·2007
7-preclinical
Changes of myocardial function after combined coronary revascularization and mitral valve downsizing in patients with ischemic mitral regurgitation and advanced cardiomyopathy.
PMID 17285466·Thorac Cardiovasc Surg·2007
8-other
New insights into the unique structure of the F0F1-ATP synthase from the chlamydomonad algae Polytomella sp. and Chlamydomonas reinhardtii.
PMID 17468226·Plant Physiol·2007
7-preclinical
Excessive erythrocytosis does not elevate capillary oxygen delivery in subcutaneous mouse tissue.
PMID 17365666·Microcirculation·2007
7-preclinical
Reliability and validity of the Milliken Activities of Daily Living Scale.
PMID 16119225·J Occup Rehabil·2005
4-observational
Downsizing of the mitral valve and coronary revascularization in severe ischemic mitral regurgitation results in reverse left ventricular and left atrial remodeling.
PMID 15896610·Eur J Cardiothorac Surg·2005
8-other
Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen.
PMID 15893010·Lung Cancer·2005
3-trial
Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer.
PMID 14679114·Ann Oncol·2004
3-trial
[Phase II-trial of tirapazamine in combination with cisplatin and gemcitabine in patients with advanced non-small-cell-lung-cancer (NSCLC)].
PMID 15597251·Pneumologie·2004
3-trial
A thermostable enzyme as an experimental platform to study properties of less stable homologues.
PMID 15333775·Protein Eng Des Sel·2004
8-other
Complete inhibition and partial Re-activation of single F1-ATPase molecules by tentoxin: new properties of the re-activated enzyme.
PMID 14739290·J Biol Chem·2004
8-other
Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
PMID 14657001·FASEB J·2004
7-preclinical
High-level expression of the Arabidopsis thaliana ethylene receptor protein ETR1 in Escherichia coli and purification of the recombinant protein.
PMID 14680944·Protein Expr Purif·2003
8-other
pO(2) measurements by phosphorescence quenching: characteristics and applications of an automated system.
PMID 12535869·Microvasc Res·2003
4-observational
Complete inhibition of the tentoxin-resistant F1-ATPase from Escherichia coli by the phytopathogenic inhibitor tentoxin after substitution of critical residues in the alpha - and beta -subunit.
PMID 12399471·J Biol Chem·2002
8-other
Difficulties in carboplatin dosage due to different methods of serum creatinine determination.
PMID 12367800·Lung Cancer·2002
8-other
Substitution of a single amino acid switches the tentoxin-resistant thermophilic F1-ATPase into a tentoxin-sensitive enzyme.
PMID 11943766·J Biol Chem·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6037 LA GRANADA, SUITE C
RANCHO SANTA FE, CA 92067 - Phone
- (858) 756-2116
Quick Facts
- NPI
- 1487759825
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile